Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 17, 2026 13:13 ET | Source: Fortrea Holdings Inc

Fortrea Expande Equipe Executiva, Nomeia Oren Cohen como Diretor Médico e Scott Dove como Presidente dos Serviços de Farmacologia Clínica

DURHAM, N.C., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (a “Empresa”), uma organização líder global de pesquisa por contrato (CRO), anunciou hoje a expansão da sua equipe executiva....
February 17, 2026 13:13 ET | Source: Fortrea Holdings Inc

Fortrea renforce son équipe de direction en nommant Oren Cohen au poste de directeur médical et Scott Dove à celui de président des services de pharmacologie clinique

DURHAM, Caroline du Nord, 17 févr. 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq : FTRE) (la « Société »), une organisation mondiale de recherche sous contrat (CRO) de premier plan, annonce ce jour...
February 17, 2026 13:13 ET | Source: Fortrea Holdings Inc

Fortrea Menambah Jajaran Anggota Tim Eksekutif dengan Mengangkat Oren Cohen sebagai Chief Medical Officer dan Scott Dove sebagai Presiden Clinical Pharmacology Services

DURHAM, North Carolina, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (“Perusahaan”), organisasi riset berbasis kontrak (CRO) global terkemuka, hari ini mengumumkan penambahan anggota tim...
February 17, 2026 13:13 ET | Source: Fortrea Holdings Inc

Fortrea Memperkukuh Pasukan Eksekutif, Dengan Perlantikan Oren Cohen sebagai Ketua Pegawai Perubatan dan Scott Dove sebagai Presiden Perkhidmatan Farmakologi Klinikal

DURHAM, North Carolina, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (“Syarikat”), sebuah organisasi penyelidikan kontrak (CRO) global terkemuka, hari ini mengumumkan pengembangan...
February 17, 2026 07:00 ET | Source: Fortrea Holdings Inc

Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services

DURHAM, N.C., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced it has expanded its executive team....
January 29, 2026 08:08 ET | Source: Fortrea Holdings Inc

Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call

DURHAM, N.C., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its fourth quarter...
January 09, 2026 11:24 ET | Source: Fortrea Holdings Inc

Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference

DURHAM, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced an updated presentation time of 11:15 am PST on...
January 06, 2026 07:00 ET | Source: Fortrea Holdings Inc

Fortrea to Present at Upcoming J.P. Morgan Healthcare Conference

DURHAM, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that CEO Anshul Thakral, CFO Jill McConnell, and SVP of...
December 10, 2025 18:00 ET | Source: Fortrea Holdings Inc

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

DURHAM, N.C., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization, today announced the granting of an inducement award of...
December 04, 2025 07:00 ET | Source: Fortrea Holdings Inc

SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery

PRAGUE, Czech Republic and DURHAM, N.C., Dec. 04, 2025 (GLOBE NEWSWIRE) -- SCTbio, a leading European CDMO specializing in GMP manufacturing for cell-based products, and Fortrea, a leading global...